Advertisement

Enucleation of the prostate for benign prostatic hyperplasia thulium laser versus holmium laser: a systematic review and meta-analysis

  • Kai-Wen Xiao
  • Liang Zhou
  • Qing He
  • Xiao-Shuai Gao
  • Guo Chen
  • Yu-Cheng Ma
  • Hong Li
  • Kun-Jie WangEmail author
Review Article

Abstract

To evaluate the clinical efficacy and safety of thulium laser vapoenucleation/enucleation of the prostate (ThuEP) versus holmium laser enucleation of the prostate (HoLEP) in the management of benign prostatic hyperplasia (BPH). A systematic literature search was performed using PubMed, Embase, and Web of Science to identify eligible studies published before July 2018. Meta-analysis of extracted data was performed with RevMan version 5.3. We chose the fixed- or random-effect model to fit the pooled heterogeneity. Five eligible studies including two randomized controlled trials (RCTs) and three non-RCTs involving 1010 patients were enrolled in our meta-analysis. ThuEP provided less enucleation time when compared with HoLEP (WMD = − 7.73, 95% CI − 14.39–1.07, P = 0.02). During the 1st, 6th, and 12th months of postoperative follow-ups, statistically significant differences were found in Qmax (WMD = 2.05, 95% CI 0.52~3.58) and PVR (WMD = − 6.50, 95% CI − 7.35~− 5.66, P < 0.001) in the 1st month after the operation, also in IPSS (IPSS: WMD = − 1.29, 95% CI − 2.39~− 0.19, P = 0.02) in the 12th month after the operation. As regards other perioperative, postoperative parameters, and complication rates, we found no significant difference. Both ThuEP and HoLEP provided satisfactory micturition improvement with low morbidity after the 1st and 6th months of the operation. However, ThuEP showed higher enucleation efficacy and less intraoperative blood loss and may get a better outcome as compared to the HoLEP group in the early postoperative period with regard to Qmax/PVR and IPSS after the 1st and 12th months of the operation respectively.

Keywords

Thulium laser Holmium laser Enucleation Safety Efficacy Meta-analysis 

Notes

Fundings

This study was supported by The National Natural Science Fund of China (81470927), National Natural Science Fund of China (81800667), and 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University.

Compliance with ethical standards

Ethical approval

Meta-analysis does not require ethical review.

Informed consent

Meta-analysis does not require informed consent.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10103_2018_2697_MOESM1_ESM.docx (18 kb)
Supplementary Table 1 (DOCX 17 kb)

References

  1. 1.
    Mcvary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE, Gonzalez CM, Kaplan SA, Penson DF (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185(5):1793–1803CrossRefGoogle Scholar
  2. 2.
    Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178CrossRefGoogle Scholar
  3. 3.
    Gratzke C, Bachmann A, Descazeaud A, Drake M, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen K, Gravas S (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109CrossRefGoogle Scholar
  4. 4.
    Foster H, Barry M, Dahm P, Gandhi M, Kaplan S, Kohler T, Lerner L, Lightner D, Parsons J, Roehrborn C, Welliver C, Wilt T, McVary K (2018) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J UrolGoogle Scholar
  5. 5.
    Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief C (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180(1):246–249CrossRefGoogle Scholar
  6. 6.
    Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50(5):969–979 discussion 980CrossRefGoogle Scholar
  7. 7.
    NB D, M S, G R, G A, N T, G K, A R, A dLT, A D, R M (2016) Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia.%A Lebdai S World journal of urology 34 (5):625–632Google Scholar
  8. 8.
    P B, MW V, LA K, L H, L M, DS E, TM K, HP S, D A (2018) Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis.%A Zumstein V. European urology focus undefined (undefined):undefinedGoogle Scholar
  9. 9.
    A M GG, N T HL, N B FB (2014) Long-term outcomes of 80-watt KTP and 120-watt HPS GreenLight photoselective vaporization of the prostate.%A Broggi. E Urologia internationalis 93(2):229–236CrossRefGoogle Scholar
  10. 10.
    A T, N B, F dA, G M, U W, MO G, J B, JU S, A R, S P, H R, F A, C S, F B, W L, T L, NK G, R H, R M, A T, N S, S G, M H, K M, M S, C C, H K, A B (2016) A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study.%A Thomas JA. Eur Urol 69 (1):94–102Google Scholar
  11. 11.
    Gilling P, Fraundorfer M (1998) Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol 8(1):11–15CrossRefGoogle Scholar
  12. 12.
    Cornu J, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67(6):1066–1096CrossRefGoogle Scholar
  13. 13.
    Li S, Zeng X, Ruan X, Weng H, Liu T, Wang X, Zhang C, Meng Z, Wang X (2014) Holmium laser enucleation versus transurethral resection in patients with benign prostate hyperplasia: an updated systematic review with meta-analysis and trial sequential analysis. PLoS One 9(7):e101615CrossRefGoogle Scholar
  14. 14.
    Yin L, Teng J, Huang C, Zhang X, Xu D (2013) Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol 27(5):604–611CrossRefGoogle Scholar
  15. 15.
    Fried N (2005) High-power laser vaporization of the canine prostate using a 110 W thulium fiber laser at 1.91 microm. Lasers Surg Med 36(1):52–56CrossRefGoogle Scholar
  16. 16.
    Xia S, Zhuo J, Sun X, Han B, Shao Y, Zhang Y (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389CrossRefGoogle Scholar
  17. 17.
    Bach T, Netsch C, Haecker A, Michel M, Herrmann T, Gross A (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28(1):39–43CrossRefGoogle Scholar
  18. 18.
    Herrmann T, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross A (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28(1):45–51CrossRefGoogle Scholar
  19. 19.
    Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, Cestari A, Briganti A, Mazzoccoli B, Rigatti P, Montorsi F (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50(3):563–568CrossRefGoogle Scholar
  20. 20.
    Kuntz R, Lehrich K, Ahyai S (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53(1):160–166CrossRefGoogle Scholar
  21. 21.
    Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647CrossRefGoogle Scholar
  22. 22.
    Higgins J, Green SE (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration (Eds). Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 5 (2):S38Google Scholar
  23. 23.
    Wells GA, Shea BJ, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P (2012) The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Applied Engineering in Agriculture 18 (6):págs. 727-734Google Scholar
  24. 24.
    Becker B, Herrmann T, Gross A, Netsch C (2018) Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of large volume prostates: preliminary 6-month safety and efficacy results of a prospective randomized trial. World J UrolGoogle Scholar
  25. 25.
    Enikeev D, Glybochko P, Okhunov Z, Alyaev Y, Rapoport L, Tsarichenko D, Enikeev M, Sorokin N, Dymov A, Taratkin M (2018) Retrospective analysis of short-term outcomes after monopolar versus laser endoscopic enucleation of the prostate: a single center experience. J Endourol 32(5):417–423CrossRefGoogle Scholar
  26. 26.
    Zhang F, Shao Q, Herrmann T, Tian Y, Zhang Y (2012) Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology 79(4):869–874CrossRefGoogle Scholar
  27. 27.
    Hong K, Liu Y, Lu J, Xiao C, Huang Y, Ma L (2015) Effect and impact of holmium laser versus thulium laser enucleation of the prostate on erectile function. Zhonghua Nan Ke Xue 21(3):245–250Google Scholar
  28. 28.
    Pirola G, Saredi G, Codas Duarte R, Bernard L, Pacchetti A, Berti L, Martorana E, Carcano G, Badet L, Fassi-Fehri H (2018) Holmium laser thulium laser enucleation of the prostate: a matched-pair analysis from two centers. Ther Adv Urol 10(8):223–233CrossRefGoogle Scholar
  29. 29.
    Bach T, Xia S, Yang Y, Mattioli S, Watson G, Gross A, Herrmann T (2010) Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol 28(2):163–168CrossRefGoogle Scholar
  30. 30.
    Ahyai S, Lehrich K, Kuntz R (2007) Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 52(5):1456–1463CrossRefGoogle Scholar
  31. 31.
    Magistro G, Chapple C, Elhilali M, Gilling P, McVary K, Roehrborn C, Stief C, Woo H, Gratzke C (2017) Emerging minimally invasive treatment options for male lower urinary tract symptoms. Eur Urol 72(6):986–997CrossRefGoogle Scholar
  32. 32.
    Gilling P, Cass C, Malcolm A, Fraundorfer M (1995) Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol 9(2):151–153CrossRefGoogle Scholar
  33. 33.
    Krambeck A, Handa S, Lingeman J (2010) Holmium laser enucleation of the prostate for prostates larger than 175 grams. J Endourol 24(3):433–437CrossRefGoogle Scholar
  34. 34.
    El-Hakim A, Elhilali M (2002) Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 90(9):863–869CrossRefGoogle Scholar
  35. 35.
    Robert G, Cornu J, Fourmarier M, Saussine C, Descazeaud A, Azzouzi A, Vicaut E, Lukacs B (2016) Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int 117(3):495–499CrossRefGoogle Scholar
  36. 36.
    Shah H, Mahajan A, Sodha H, Hegde S, Mohile P, Bansal M (2007) Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol 177(4):1468–1474CrossRefGoogle Scholar
  37. 37.
    Gross A, Netsch C, Knipper S, Hölzel J, Bach T (2013) Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol 63(5):859–867CrossRefGoogle Scholar
  38. 38.
    Krambeck A, Handa S, Lingeman J (2013) Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol 189(1 Suppl):S141–S145CrossRefGoogle Scholar
  39. 39.
    Netsch C, Bach T, Herrmann T, Gross A (2012) Thulium:YAG VapoEnucleation of the prostate in large glands: a prospective comparison using 70- and 120-W 2-μm lasers. Asian J Androl 14(2):325–329CrossRefGoogle Scholar
  40. 40.
    Minagawa S, Okada S, Morikawa H (2017) Safety and effectiveness of holmium laser enucleation of the prostate using a low-power laser. Urology 110:51–55CrossRefGoogle Scholar
  41. 41.
    Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel M, Häcker A (2008) Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 22(5):1041–1045CrossRefGoogle Scholar
  42. 42.
    PJ G (2015) HoLEP has come of age.%A Vincent MW. World J Urol 33(4):487–493CrossRefGoogle Scholar
  43. 43.
    PB I (2018) Advances in laser technology and fibre-optic delivery systems in lithotripsy.%A Fried NM. Nat Rev Urol 15(9):563–573CrossRefGoogle Scholar
  44. 44.
    Netsch C, Bach T, Herrmann T, Neubauer O, Gross A (2013) Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach. World J Urol 31(5):1231–1238CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2019

Authors and Affiliations

  • Kai-Wen Xiao
    • 1
  • Liang Zhou
    • 1
  • Qing He
    • 1
  • Xiao-Shuai Gao
    • 1
  • Guo Chen
    • 1
  • Yu-Cheng Ma
    • 1
  • Hong Li
    • 1
  • Kun-Jie Wang
    • 1
    Email author
  1. 1.Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China HospitalSichuan UniversityChengduPeople’s Republic of China

Personalised recommendations